GLASF
Price
$7.55
Change
+$0.29 (+3.99%)
Updated
Sep 5 closing price
Capitalization
583.26M
LFCR
Price
$7.53
Change
-$0.41 (-5.16%)
Updated
Sep 5 closing price
Capitalization
281.68M
26 days until earnings call
Interact to see
Advertisement

GLASF vs LFCR

Header iconGLASF vs LFCR Comparison
Open Charts GLASF vs LFCRBanner chart's image
Glass House Brands
Price$7.55
Change+$0.29 (+3.99%)
Volume$119.09K
Capitalization583.26M
Lifecore Biomedical
Price$7.53
Change-$0.41 (-5.16%)
Volume$138.55K
Capitalization281.68M
GLASF vs LFCR Comparison Chart in %
Loading...
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLASF vs. LFCR commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Hold and LFCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GLASF: $7.55 vs. LFCR: $7.53)
Brand notoriety: GLASF and LFCR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GLASF: 37% vs. LFCR: 109%
Market capitalization -- GLASF: $583.26M vs. LFCR: $281.68M
GLASF [@Pharmaceuticals: Generic] is valued at $583.26M. LFCR’s [@Pharmaceuticals: Generic] market capitalization is $281.68M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLASF’s FA Score shows that 0 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • GLASF’s FA Score: 0 green, 5 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, LFCR is a better buy in the long-term than GLASF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLASF’s TA Score shows that 4 TA indicator(s) are bullish while LFCR’s TA Score has 3 bullish TA indicator(s).

  • GLASF’s TA Score: 4 bullish, 6 bearish.
  • LFCR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both GLASF and LFCR are a bad buy in the short-term.

Price Growth

GLASF (@Pharmaceuticals: Generic) experienced а -8.48% price change this week, while LFCR (@Pharmaceuticals: Generic) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

LFCR is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLASF($583M) has a higher market cap than LFCR($282M). GLASF has higher P/E ratio than LFCR: GLASF (513.07) vs LFCR (51.23). GLASF YTD gains are higher at: 30.172 vs. LFCR (1.346). GLASF has higher annual earnings (EBITDA): 49M vs. LFCR (-8.81M). GLASF has more cash in the bank: 40.7M vs. LFCR (8.27M). GLASF has less debt than LFCR: GLASF (72.8M) vs LFCR (131M). GLASF has higher revenues than LFCR: GLASF (222M) vs LFCR (129M).
GLASFLFCRGLASF / LFCR
Capitalization583M282M207%
EBITDA49M-8.81M-556%
Gain YTD30.1721.3462,242%
P/E Ratio513.0751.231,001%
Revenue222M129M172%
Total Cash40.7M8.27M492%
Total Debt72.8M131M56%
FUNDAMENTALS RATINGS
GLASF vs LFCR: Fundamental Ratings
GLASF
LFCR
OUTLOOK RATING
1..100
223
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
4240
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLASF's Valuation (94) in the null industry is in the same range as LFCR (99) in the Industrial Specialties industry. This means that GLASF’s stock grew similarly to LFCR’s over the last 12 months.

GLASF's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that GLASF’s stock grew similarly to LFCR’s over the last 12 months.

GLASF's SMR Rating (94) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that GLASF’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (40) in the Industrial Specialties industry is in the same range as GLASF (42) in the null industry. This means that LFCR’s stock grew similarly to GLASF’s over the last 12 months.

LFCR's P/E Growth Rating (7) in the Industrial Specialties industry is significantly better than the same rating for GLASF (100) in the null industry. This means that LFCR’s stock grew significantly faster than GLASF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLASFLFCR
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBNKF15.10N/A
N/A
Nordea Bank Abp
QURT0.60N/A
N/A
Quarta-Rad, Inc.
SVAUF3.38N/A
N/A
Storagevault Canada Inc.
GZPZY36.86N/A
N/A
Gaztransport & Tecnigaz
DBLVF0.44-0.03
-6.36%
Doubleview Gold Corp.

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
+3.99%
TSNDF - GLASF
63%
Loosely correlated
+13.08%
GTBIF - GLASF
62%
Loosely correlated
+4.55%
TCNNF - GLASF
60%
Loosely correlated
+4.55%
VRNOF - GLASF
58%
Loosely correlated
+5.51%
CURLF - GLASF
57%
Loosely correlated
+1.79%
More

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-5.16%
NBIX - LFCR
36%
Loosely correlated
+2.64%
SHPH - LFCR
31%
Poorly correlated
-1.17%
TKNO - LFCR
27%
Poorly correlated
+2.83%
TLRY - LFCR
27%
Poorly correlated
+3.48%
ALKS - LFCR
26%
Poorly correlated
+3.53%
More